ARWR logo

ARWR

Profile

Full Name

Arrowhead Pharmaceuticals, Inc.

Ticker Symbol

ARWR

Exchange

NASDAQ

Country

United States

IPO

December 16, 1993

Indexes

Not included

Employees

609

Key Details

Price

$12.53

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$3.55M(-98.52% YoY)

Annual EPS

-$5.00(-160.42% YoY)

PE Ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Feb 14, 25 B. Riley Securities
Buy
Feb 12, 25 HC Wainwright & Co.
Buy
Feb 11, 25 RBC Capital
Outperform
Feb 11, 25 Chardan Capital
Buy
Jan 23, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Dec 20, 24 HC Wainwright & Co.
Buy
Dec 12, 24 Chardan Capital
Buy
Dec 3, 24 HC Wainwright & Co.
Buy
Nov 29, 24 Bernstein
Market Perform

Institutional Ownership

  • What is the ticker symbol for Arrowhead Pharmaceuticals?
  • Does Arrowhead Pharmaceuticals pay dividends?
  • What sector is Arrowhead Pharmaceuticals in?
  • What industry is Arrowhead Pharmaceuticals in?
  • What country is Arrowhead Pharmaceuticals based in?
  • When did Arrowhead Pharmaceuticals go public?
  • Is Arrowhead Pharmaceuticals in the S&P 500?
  • Is Arrowhead Pharmaceuticals in the NASDAQ 100?
  • Is Arrowhead Pharmaceuticals in the Dow Jones?
  • When was Arrowhead Pharmaceuticals's last earnings report?
  • When does Arrowhead Pharmaceuticals report earnings?
  • Should I buy Arrowhead Pharmaceuticals stock now?

What is the ticker symbol for Arrowhead Pharmaceuticals?

The ticker symbol for Arrowhead Pharmaceuticals is NASDAQ:ARWR

Does Arrowhead Pharmaceuticals pay dividends?

No, Arrowhead Pharmaceuticals does not pay dividends

What sector is Arrowhead Pharmaceuticals in?

Arrowhead Pharmaceuticals is in the Healthcare sector

What industry is Arrowhead Pharmaceuticals in?

Arrowhead Pharmaceuticals is in the Biotechnology industry

What country is Arrowhead Pharmaceuticals based in?

Arrowhead Pharmaceuticals is headquartered in United States

When did Arrowhead Pharmaceuticals go public?

Arrowhead Pharmaceuticals's initial public offering (IPO) was on December 16, 1993

Is Arrowhead Pharmaceuticals in the S&P 500?

No, Arrowhead Pharmaceuticals is not included in the S&P 500 index

Is Arrowhead Pharmaceuticals in the NASDAQ 100?

No, Arrowhead Pharmaceuticals is not included in the NASDAQ 100 index

Is Arrowhead Pharmaceuticals in the Dow Jones?

No, Arrowhead Pharmaceuticals is not included in the Dow Jones index

When was Arrowhead Pharmaceuticals's last earnings report?

Arrowhead Pharmaceuticals's most recent earnings report was on Feb 10, 2025

When does Arrowhead Pharmaceuticals report earnings?

The next expected earnings date for Arrowhead Pharmaceuticals is May 9, 2025

Should I buy Arrowhead Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page